Treating substance misuse requires a multipronged approach that encompasses prevention, treatment, and recovery. We are at the forefront of driving and supporting the health care practices and policies needed to care for those with substance use disorder. We also contribute to reducing the prevalence of substance misuse, including that of alcohol, tobacco, opioids, and other drugs.
For over 25 years, we have worked with states, communities, and workplaces to address alcohol, drug, and tobacco use. In the midst of an opioid crisis and global pandemic, with its disproportionate effect on underserved communities, we are helping to develop and implement evidence-based programs to decrease substance misuse and opioid-related morbidity and mortality.
We recognize the need for leadership, financial investment, innovative approaches, and research to identify the best practices for reducing the prevalence of substance use disorders. Further, we support new efforts to integrate knowledge and effective responses into emergency services, primary care, and specialty health care settings.
In collaboration with clients, we provide training and technical assistance to enhance treatment and prevention initiatives, data analysis, community surveys, communications, and strategic planning. We also offer evaluation and monitoring as programs are being implemented.